BACKGROUND: Isolated tumor cells (ITC) are more likely to be identified when serial sectioning and immunohistochemical staining are used to evaluate sentinel lymph nodes (SLN). Our goal was to identify clinicopathologic features associated with ITC in patients undergoing sentinel lymph node dissection (SLND). METHODS: We reviewed clinicopathologic data for 3557 patients with no clinical evidence of lymph node metastases undergoing SLND between November 1993 and March 2007. Patients were staged according to the 6th edition of the American Joint Committee on Cancer staging system, with metastasis <or=.2 mm classified as ITC. RESULTS: A SLN was identified in 3475 patients (97.7%), including 2518 (72.4%) with negative nodes and 169 (4.9%) with ITC. A statistically significant association existed between lobular histology and the identification of ITC; 13.6% of patients with ITC had lobular histology versus 7.3% of patients with a negative SLN (P = .003). The presence of lymphovascular invasion (LVI) was also associated with ITC; 18.3% of patients with ITC had LVI in the primary tumor versus 8.5% of patients with a negative SLN (P < .001). No difference existed between patients with and without ITC with respect to T stage, grade, estrogen receptor, progesterone receptor, HER2/neu status, or biopsy method. CONCLUSION: The association between ITC and LVI, a known predictor of poor outcome, suggests ITC may have clinical relevance. The relationship between lobular histology and ITC is consistent with the known pattern of lobular metastases, which frequently present as small foci requiring immunohistochemistry for detection. Longer follow-up is needed to determine whether ITC have prognostic significance.
BACKGROUND: Isolated tumor cells (ITC) are more likely to be identified when serial sectioning and immunohistochemical staining are used to evaluate sentinel lymph nodes (SLN). Our goal was to identify clinicopathologic features associated with ITC in patients undergoing sentinel lymph node dissection (SLND). METHODS: We reviewed clinicopathologic data for 3557 patients with no clinical evidence of lymph node metastases undergoing SLND between November 1993 and March 2007. Patients were staged according to the 6th edition of the American Joint Committee on Cancer staging system, with metastasis <or=.2 mm classified as ITC. RESULTS: A SLN was identified in 3475 patients (97.7%), including 2518 (72.4%) with negative nodes and 169 (4.9%) with ITC. A statistically significant association existed between lobular histology and the identification of ITC; 13.6% of patients with ITC had lobular histology versus 7.3% of patients with a negative SLN (P = .003). The presence of lymphovascular invasion (LVI) was also associated with ITC; 18.3% of patients with ITC had LVI in the primary tumor versus 8.5% of patients with a negative SLN (P < .001). No difference existed between patients with and without ITC with respect to T stage, grade, estrogen receptor, progesterone receptor, HER2/neu status, or biopsy method. CONCLUSION: The association between ITC and LVI, a known predictor of poor outcome, suggests ITC may have clinical relevance. The relationship between lobular histology and ITC is consistent with the known pattern of lobular metastases, which frequently present as small foci requiring immunohistochemistry for detection. Longer follow-up is needed to determine whether ITC have prognostic significance.
Authors: Aeisha K Rivers; Kent A Griffith; Kelly K Hunt; Amy C Degnim; Michael S Sabel; Kathleen M Diehl; Vincent M Cimmino; Alfred E Chang; Peter C Lucas; Lisa A Newman Journal: Ann Surg Oncol Date: 2006-01-01 Impact factor: 5.344
Authors: Judy C Boughey; Isabelle Bedrosian; Funda Meric-Bernstam; Merrick I Ross; Henry M Kuerer; Jeri S Akins; Sharon H Giordano; Gildy V Babiera; Frederick C Ames; Kelly K Hunt Journal: J Am Coll Surg Date: 2006-08-23 Impact factor: 6.113
Authors: Nils M Diaz; Charles E Cox; Mark Ebert; John D Clark; Vesna Vrcel; Nicholas Stowell; Anu Sharma; James W Jakub; Alan Cantor; Barbara A Centeno; Elisabeth Dupont; Carlos Muro-Cacho; Santo Nicosia Journal: Am J Surg Pathol Date: 2004-12 Impact factor: 6.394
Authors: Charles Cox; Laura White; Nathon Allred; Michael Meyers; Daniel Dickson; Elisabeth Dupont; Alan Cantor; Quan Ly; Sophie Dessureault; Jeff King; Santo Nicosia; Vesna Vrcel; Nils Diaz Journal: Ann Surg Oncol Date: 2006-03-16 Impact factor: 5.344
Authors: G Cserni; S Bianchi; V Vezzosi; H Peterse; A Sapino; R Arisio; A Reiner-Concin; P Regitnig; J-P Bellocq; C Marin; R Bori; J M Penuela; A Córdoba Iturriagagoitia Journal: J Clin Pathol Date: 2006-02-23 Impact factor: 3.411
Authors: José Luiz B Bevilacqua; Michael W Kattan; Jane V Fey; Hiram S Cody; Patrick I Borgen; Kimberly J Van Zee Journal: J Clin Oncol Date: 2007-07-30 Impact factor: 44.544
Authors: Elizabeth A Mittendorf; Kelly K Hunt; Judy C Boughey; Roland Bassett; Amy C Degnim; Robyn Harrell; Min Yi; Funda Meric-Bernstam; Merrick I Ross; Gildy V Babiera; Henry M Kuerer; Rosa F Hwang Journal: Ann Surg Date: 2012-01 Impact factor: 12.969
Authors: Önder Karahallı; Turan Acar; Murat Kemal Atahan; Nihan Acar; Mehmet Hacıyanlı; Kemal Erdinç Kamer Journal: Indian J Surg Date: 2016-05-04 Impact factor: 0.656
Authors: Abigail S Caudle; Kelly K Hunt; Henry M Kuerer; Funda Meric-Bernstam; Anthony Lucci; Isabelle Bedrosian; Gildy V Babiera; Rosa F Hwang; Merrick I Ross; Barry W Feig; Karen Hoffman; Jennifer K Litton; Aysegul A Sahin; Wei Yang; Gabriel N Hortobagyi; Thomas A Buchholz; Elizabeth A Mittendorf Journal: Ann Surg Oncol Date: 2011-09 Impact factor: 5.344
Authors: Elizabeth A Mittendorf; Karla V Ballman; Linda M McCall; Min Yi; Aysegul A Sahin; Isabelle Bedrosian; Nora Hansen; Sheryl Gabram; Thelma Hurd; Armando E Giuliano; Kelly K Hunt Journal: J Clin Oncol Date: 2014-12-08 Impact factor: 44.544
Authors: Abigail S Caudle; Kelly K Hunt; Susan L Tucker; Karen Hoffman; Sarah M Gainer; Anthony Lucci; Henry M Kuerer; Funda Meric-Bernstam; Ruchita Shah; Gildy V Babiera; Aysegul A Sahin; Elizabeth A Mittendorf Journal: Ann Surg Oncol Date: 2012-07-31 Impact factor: 5.344